SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $242,188 | -10.5% | 403,782 | +94.1% | 0.00% | -50.0% |
| Q2 2023 | $270,462 | -70.6% | 208,048 | -60.1% | 0.00% | -66.7% |
| Q1 2023 | $918,704 | +149.0% | 521,991 | +344.2% | 0.01% | +200.0% |
| Q4 2022 | $369,026 | -42.0% | 117,524 | -9.4% | 0.00% | -60.0% |
| Q3 2022 | $636,000 | +55.1% | 129,789 | +31.1% | 0.01% | +66.7% |
| Q2 2022 | $410,000 | -38.3% | 99,010 | +144.2% | 0.00% | -75.0% |
| Q4 2017 | $665,000 | +41.5% | 40,540 | +29.4% | 0.01% | +33.3% |
| Q3 2017 | $470,000 | – | 31,340 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |